Cerner Signs DoseEdge Strategic Reseller Agreement with Baxa
Kansas City, Missouri and Englewood, Colorado, December 6, 2010—Cerner Corporation and Baxa Corporation have signed a strategic reseller agreement for the Baxa DoseEdge™ Pharmacy Workflow Manager. Cerner Corporation (Nasdaq: CERN) and Baxa Corporation have signed a strategic reseller agreement for the Baxa DoseEdge Pharmacy Workflow Manager. The agreement enables Cerner to market and resell the Baxa DoseEdge System as part of an integrated Cerner offering. Cerner clients now have access to a broader suite of solutions and certified integration for dose tracking from compounding to delivery.
“The agreement expands our offering and positions Cerner to continue increasing interoperability across the medication process,” says Tom Herzog, Cerner vice president, IT and medical device technologies. Dennis Schneider, Baxa senior VP of marketing and business development, agrees, “Together, the Baxa and Cerner® solutions increase IV room efficiency and advance patient safety. Their interoperability will reduce drug waste and improve communication about patient doses between pharmacy and nursing.”
The Cerner partnership will allow health systems to improve their IV room automation by integrating DoseEdge technology with Cerner solutions to create a closed-loop system for medication preparation, management and delivery. DoseEdge connects to the Cerner CareAware® Infusion Management and Cerner Millennium PharmNet® solutions to move critical IV mixing data to the electronic health record.
Baxa and Cerner will work together to assist Cerner clients in their evaluation and implementation of Cerner-integrated DoseEdge. This unique offering of Cerner-integrated DoseEdge is available only from Cerner. Cerner and Baxa have begun work on integration planning, and will communicate further with clients during the first quarter of 2011.
About Cerner
Cerner is transforming healthcare by eliminating error, variance and waste for healthcare providers and consumers around the world. Cerner® solutions optimize processes for healthcare organizations ranging in size from single-doctor practices, to health systems, to entire countries, for the pharmaceutical and medical device industries, employer health and wellness services industry and for the healthcare commerce system. These solutions are licensed by more than 8,500 facilities around the world, including approximately 2,300 hospitals; 3,400 physician practices covering more than 30,000 physicians; 600 ambulatory facilities, such as laboratories, ambulatory centers, cardiac facilities, radiology clinics and surgery centers; 700 home-health facilities; and 1,500 retail pharmacies. The trademarks, service marks and logos (collectively, the “Marks”) set forth herein are registered and unregistered trademarks and/or service marks owned by Cerner Corporation and/or its subsidiaries in the United States and certain other countries throughout the world. Nasdaq: CERN. For more information about Cerner, please visit www.cerner.com, Twitter, Facebook, and YouTube.
About Baxa Corporation
Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for medication handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of medications. Key products include the Abacus® Order Entry and Calculation Software, the DoseEdge™ Pharmacy Workflow Manager, ExactaMed® Oral Syringes, ExactaMix™ Automated Compounding Devices, InFuse™ and MicroFuse® Syringe Infusers, Repeater™ Pharmacy Pumps, NeoThrive® Enteral Syringes, the PadLock® Set Saver and the RapidFill™ Automated Syringe Filler; used worldwide in hospitals and healthcare facilities. Its subsidiary FHT, Inc. produces the IntelliFill® i.v. automation. Privately held, Baxa Corporation has subsidiaries and sales offices in Florida, Canada and the United Kingdom; direct representation in Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, The Netherlands and Switzerland; and distribution partners worldwide. Further information is available at www.baxa.com.